Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name BI 765049
Trade Name
Synonyms BI-765049|BI765049
Drug Descriptions

BI 765049 is a bispecific T-cell engager (BiTE) that targets tumor-expressed NCR3LG1 (B7-H6) and CD3 expressed on T-cells, potentially leading to increased migration of T-lymphocytes to the tumor, resulting in tumor cell apoptosis and decreased tumor growth (J Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS3175-TPS3175).

DrugClasses CD3 Antibody 96
CAS Registry Number NA


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BI 765049 BI 765049 0 1
BI 765049 + Ezabenlimab BI 765049 Ezabenlimab 0 1

Additional content available in CKB BOOST